Fencino® is bioequivalent to Durogesic® DTrans®
The pharmacokinetic data submitted to the Regulatory Authorities demonstrated the interchangeability of Fencino® and the originator product.
Our company mission is to provide high quality, sustained release medicines which save money and where possible, provide improved benefits for patients.
Fencino® saves the NHS 32% on fentanyl patch prescription costs.2
Ethypharm will guarantee that the price of Fencino® will not increase until April 2019 when the next PPRS agreement is scheduled to be agreed and signed.